| [1] |
YANG Xiaofang, JIA Xinyan, FENG Wenjun.
MiR-181a-5p regulates the proliferation and apoptosis of glomerular mesangial cells in lupus nephritis mice through HMGB1/NF-κB signaling pathway
[J]. Tianjin Medical Journal, 2026, 54(3): 232-237.
|
| [2] |
HUANG Huiqi, WU Qiuyuan, ZHANG Kun, LI Peixian, XIONG Yaming, YE Guolin, ZHOU Dan.
Research on the anti-tumor mechanism of toosendanin combined with olaparib in triple negative breast cancer
[J]. Tianjin Medical Journal, 2025, 53(9): 897-902.
|
| [3] |
SONG Shanshan, JIANG Min, WANG Liang, HUANG Bozhen, WANG Guoyu, LIU Xinxin, MA Siyi.
The global burden of tracheal, bronchial and lung cancer disease from 1990 to 2021 and the forecast to 2040
[J]. Tianjin Medical Journal, 2025, 53(8): 875-883.
|
| [4] |
WANG Haicheng, ZHAO Yihan, XIE Meiyi, ZHAO Yuming.
Predictive value of SUVmax and SUVmean parameters in 18F-PSMA-1007 PET/CT for the diagnosis and disease progression of prostate cancer
[J]. Tianjin Medical Journal, 2025, 53(6): 614-618.
|
| [5] |
ZHOU Meijuan, MIAO Xiaoxiang.
Relationship between serum expression levels of miR-214-3p and miR-124-3p and the severity of disease in patients with Parkinson's disease and their values in early diagnosis
[J]. Tianjin Medical Journal, 2025, 53(5): 498-502.
|
| [6] |
QI Weihua, HUANG Guanglei, ZHANG Yuanyuan, BAN Hongying, MAO Zhaoxu.
Effect of forsythigenin on the malignant progression of lung cancer cells by regulating the cAMP/EPAC1/RAP1 signal pathway
[J]. Tianjin Medical Journal, 2025, 53(4): 343-348.
|
| [7] |
WANG Chao, ZHANG Junmei, ZHANG Peng, LIU Li, WANG Xiaochun.
Comparison of efficacy of recombinant human interleukin-11 and herombopag olamine tablets on chemotherapy-induced thrombocytopenia in breast cancer
[J]. Tianjin Medical Journal, 2025, 53(4): 365-369.
|
| [8] |
LI Na, HE Ying, TENG Fei, HE Wenshu, GUO Caifeng, ZHONG Na, WU Qiong, LI Jun.
The application value of ultrasound BI-RADS classification combined with serum FGFR1 and GDF3 in the differential diagnosis of benign and malignant breast masses
[J]. Tianjin Medical Journal, 2025, 53(3): 247-251.
|
| [9] |
WANG Wei, XIA Haishui, MA Shang.
Efficacy of trastuzumab combined with neratinib in the treatment of HER-2 positive metastatic breast cancer
[J]. Tianjin Medical Journal, 2025, 53(3): 321-325.
|
| [10] |
WANG Linna, WANG Di, DONG Yanhong.
Clinical effect of aribulin combined with NP regimen in the treatment of patients with advanced breast cancer
[J]. Tianjin Medical Journal, 2025, 53(3): 326-330.
|
| [11] |
HUANG Xiaoqing, LIU Yuanyuan, YAN Liang, YI Shuping.
Dosimetric comparison of two irradiation modes after radical mastectomy for breast cancer
[J]. Tianjin Medical Journal, 2025, 53(11): 1204-1207.
|
| [12] |
HU Limei, LIU Huiying, CHEN Yaru, ZHAO Panpan, GU Jun, REN Weidong.
Clinical efficacy of caragliflozin and empagliflozin in obese patients with type 2 diabetes mellitus
[J]. Tianjin Medical Journal, 2025, 53(10): 1071-1076.
|
| [13] |
LIU Yuanyuan, HUANG Xiaoqing, YAN Liang, YI Shuping.
Preventive efficacy of rhGM-CSF combined with Kangfuxin liquid on radiation dermatitis of breast cancer
[J]. Tianjin Medical Journal, 2025, 53(10): 1076-1080.
|
| [14] |
ZHANG Zhihua, CHANG Taihao, LUO Fei, WANG Yashen, LI Jian.
Efficacy and safety of simultaneous prostate biopsy combined with PVP in the treatment of elderly, high-risk and suspected prostate cancer patients
[J]. Tianjin Medical Journal, 2024, 52(9): 959-962.
|
| [15] |
XIAO Xiaoli, XIE Yao, LONG Zhi.
Changes and clinical significance of serum miR-155 and miR-205-5p expression levels in patients with hepatitis C virus infection
[J]. Tianjin Medical Journal, 2024, 52(9): 967-970.
|